Oct 20 (Reuters) – Procter & Gamble Co disappointed
Wall Street with sales on Friday, hurt by continuing weakness in
its Gillette business, a week after it claimed to have fought
off hedge-fund manager Nelson Peltz’s move to muscle onto the
board.

Read More At Article Source | Article Attribution